DIAN Target Validation Symposium Agenda

Welcome/Open Remarks: May 25

Dr. Randall Bateman, MD- Washington University School of Medicine, St. Louis, Mo

Presentations

Primers on Target Validation: How we validate and factors that influence robustness- 8:45am

Moderator: Dr. Todd Golde, MD, PhD

Presenters:

Dr. Eric Karran, PhD– Vice President, Distinguished Research Fellow, Neuroscience and Ophthalmology Discovery Research at AbbVie

Dr. Geoffrey A. Kerchner, MD, PhD– Vice President and Global Head of Early Development in Neuroscience and Rare Disease at F. Hoffman- La Roche, Ltd

Panelist: Dr. Jaren Landen, PhD; Dr. Eric Karran, PhD, Dr. Geoffrey Kerchner, MD, PhD

Known Amyloid Target Validation- 10:30am

Moderator: Dr. Tammie Benzinger, MD, PhD

Presenters:

Dr. Lucia Chavez-Gutierrez, PhD– VIB-KU Leuven Center for Brain and Disease Research,  Leuven, Belgium

Dr. Jasmeer Chhawtal, MD, PhD– Harvard Medical School, Boston, MA

Panelist: Randall J. Bateman, MD; Dr. Colin Masters, MD; Dr. Lucia Chavez-Gutierrez, PhD; Dr. Jasmeer Chhawtal, MD, PhD

Known Tau Target Validation- 1:00pm

Moderator: Dr. Eric McDade, DO

Presenters:

Dr. Nicolas Barthelemy, PhD– Washington University School of Medicine, St. Louis, MO

Dr. Oskar Hansson, PhD– Lund University, Lund, Sweden

Panelist: Dr. Judith Steen, PhD; Dr. Jeff Dage, PhD; Dr. Nicolas Barthelemy, PhD; Dr. Oskar Hansson, PhD

Potential Omics Target Validation-2:45pm

Moderator: Dr. Allan Levey, MD, PhD

 Presenters:

Dr. Erik Johnson, MD, PhD– Emory University, Atlanta, Georgia

Dr. Celeste Karch, PhD– Washington University School of Medicine, St. Louis, Mo

Panelists: Dr. Li-Huei Tsai, PhD; Dr. Laura Ibanez, PhD; Dr. Erik Johnson, MD, PhD; Dr. Celeste Karch, PhD

 

Opening Remarks: May 26

 Dr. Randall Bateman, MD- Washington University of Medicine, St. Louis, Mo

 Presentations

Biomarkers for non-Amyloid/non Tau Target Validation- 8:45am

Moderator: Dr. Johannes Levin, MD

Presenters:

Dr. Charlotte Teunissen, PhD – Amsterdam University Medical Centers, Amsterdam, Netherlands

Dr. Marc Suárez-Calvet, MD, PhD–  BarcelonaBeta Brain Research Center (BBRC), Barcelona, Spain

Panelists: Dr. Naresha Saligrama, PhD; Dr. Pedro Rosa-Neto, MD, PhD; Dr. Charlotte Teunissen, PhD; Dr. Marc Suarez- Calvet, MD, PhD

Clinical/Cognitive Validation of Targets- 10:30am

Moderator: Dr. Jorge Llibre-Guerra, MD, MS

Presenters:

Dr. Lynn Kramer, MD, FAAN– Chief Clinical Officer, Alzheimer’s Disease & Brain Health at Eisai

Dr. Paul Maruff, PhD– Chief Innovation Officer at Cogstate, Ltd and Professor at the Alzheimer’s Disease Research Group, Florey Institute for Neuroscience at the University of Melbourne, Australia

Panelists: Dr. Jason Hassenstab, PhD; Dr. Eric McDade, DO; Dr. Kathy Welsh-Bohmer, PhD; Dr. Lynn Kramer, MD; Dr. Paul Maruff, PhD

Protective/Escapee-1:00pm

Moderator: Dr. Alison Goate, DPhil

Presenter:

Dr. Yakeel T. Quiroz, PhD– Harvard Medical School, Boston, MA

Panelists: Dr. Jorge Llibre-Guerra, MD, MS; Dr. Alison Goate, DPhil; Dr. Yakeel Quiroz, PhD

Disease Modification- 1:45pm

Moderator: Dr. Randall J. Bateman, MD

 Presenters:

Dr. Randall Bateman, MD– Washington University School of Medicine, St, Louis Mo

Dr. Alireza Atri, MD, PhD– Director at Banner Sun Health Research Institute, Sun City , AZ

Panelist: Dr. Allan Levey, MD, PhD; Dr. Michael Irizzary, MD, MPH; Dr. Randall Bateman, MD; Dr. Alireza Atri, MD, PhD